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TonsillectomyAbstract Background: Sevoﬂurane-related emergence agitation (EA) is considered a signiﬁcant
problem that interferes with children’s recovery; our aim was to evaluate the efﬁcacy of nebulized
lidocaine hydrochloride when given before sevoﬂurane anesthesia in attenuating EA in children
undergoing tonsillectomy.
Materials and methods: A randomized clinical study was conducted on eighty children ASA I and II
who underwent tonsillectomy. The children were randomized to one of two groups according to the
nebulizer contents. Lidocaine group (group L) received nebulized solution of 4 mg/kg lidocaine hydro-
chloride and placebo group (group P) received nebulized solution contains 0.9% normal saline.
Results: The number of agitated patients were signiﬁcantly lowered in the lidocaine group compared to
the placebo group; p value (0.012).
Conclusion: The use of nebulized lidocaine before sevoﬂurane anesthesia for pediatric patients under-
going tonsillectomy attenuated the sevoﬂurane-related EA with no side effects.
ª 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.D license.1. Introduction
Sevoﬂurane is the most commonly used inhaled anesthetic in
children, due to its pleasant smell and low blood gas solubilitycoefﬁcient that lead to rapid induction and recovery [1]. How-
ever, emergence agitation (EA) occurs in up to 80% of pediat-
ric patients receiving sevoﬂurane [2]. In addition to the stress
imposed on both caregivers and the family, it is considered
as a potentially serious complication due to the possibility of
self-injury.
Otolaryngeal procedures are considered as one of the
independent risk factors for EA [3]. Although the exact eti-
ology of sevoﬂurane EA is still unclear, rapid emergence,
variable neurological recovery, and increased sensation of
pain are the proposed causes of EA related to sevoﬂurane
(4). Different techniques have been used to attenuate the
EA including propofol, narcotics, ketamine, and alpha 2-
agonists [1,2,5–7]. However, these techniques may interfere
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sedation on arrival to the recovery room.
Lidocaine hydrochloride is a widely available local anes-
thetic with a good safety proﬁle when given by nebulization
[8]. It is frequently nebulized before bronchoscopy procedures,
allowing the bronchoscope to reach greater depths in the air-
way. Lidocaine levels in the blood after nebulization for adults
at normal doses were found to be safe [9]. Also, lidocaine was
given by nebulization for ﬂexible bronchoscopy in children in
doses 4 and 8 mg/kg of 2% lidocaine and was well tolerated
with no side effects, or symptoms of toxicity [10].
We hypothesized that achieving preemptive analgesia
using preoperative lidocaine nebulization for pediatric pa-
tients undergoing tonsillectomies with sevoﬂurane anesthesia
can result in less EA without excessive sedation in recovery
room.
We conducted this double-blind, placebo-controlled, ran-
domized study to evaluate the efﬁcacy of nebulized lidocaine
when given before sevoﬂurane anesthesia for children undergo-
ing tonsillectomy in attenuating EA.Table 1 Five-point emergence agitation scale [12].
Score
1 Obtunded with no response to stimuli
2 Asleep, but responsive to movement and stimuli
3 Awake and appropriately responsive
4 Crying and diﬃcult to console
5 Wild thrashing behavior that requires restraint1.1. Material and methods
After approval of the ethical committee at Saad Specialist
Hospital, Saudi Arabia, written informed consents were ob-
tained from the parents of 80 children ASA physical status I
and II aged 4–6 years old, undergoing tonsillectomy under
general anesthesia during the period from April to October
2012. Children with history of cardiovascular, neurologic
and liver diseases, bronchial asthma, obstructive sleep apnea,
recent upper respiratory tract infection within the previous
2 weeks, and patients in whom surgery had taken more than
1 h were excluded from this study.
The children were randomly divided using closed envelope
technique for randomization to one of two groups according
to the nebulizer contents:
Group L (n= 40): Lidocaine group received nebulized
solution of 4 mg/kg lidocaine.
Group P (n= 40): Placebo group received nebulized solu-
tion contains 0.9% normal saline.
The study drug consisted of identically labeled 5 ML vials;
the contents of the vials were only known to the pharmacy
department, of either:
¤ Lidocaine hydrochloride (Astra Zeneca, New South
Wales, Australia.) calculated to be equal to 4 mg/kg of
lidocaine 2% and then normal saline is added to make
the study solution up to 5 ml; hence, the lidocaine concen-
tration was variable and dependent on the child’s weight.
¤ Or 0.9% normal saline (placebo) 5 ml.
The solution was applied to the patient by face mask and
a compressed gas-powered jet nebulizer with 6 L/min oxy-
gen. The child was asked to inhale deeply.
The nebulizers were given by the nurses in the holding area
according to the instruction written in the sealed envelope; the
anesthesiologists in charge of the case were unaware of the
component of the nebulizer except in emergency conditions
in order to ensure the double-blind nature of the study.All children were fasting 6 h before surgery and an intrave-
nous cannula (24 or 22 gauge) was inserted to all of them on
admission to the hospital. Lactated Ringer’s solution started
at the standard maintenance ﬂuid therapy according to the pa-
tient’s weight.
All patients received atropine 0.01 mg/kg followed by keta-
mine 1 mg/kg intravenously as a premedication and to facili-
tate separation from the parents just before shifting to the
operating room. In the operating room, the ECG, pulse oxim-
eter, and noninvasive arterial blood pressure monitor were at-
tached and the anesthesia was induced to all patients with
fentanyl 2 lg/kg, sevoﬂurane 2–8%, and atracurium 0.5 mg/
kg. Orotracheal intubation was done using a suitable size,
lubricated tube. Anesthesia was maintained with sevoﬂurane
2% in 50:50% O2/N2O with pressure controlled mode of ven-
tilation aiming to maintain etco2 between 30 and 35 mmHg.
Spo2, etco2, heart rate, and noninvasive arterial blood pressure
were monitored. Immediately after intubation, a suppository
of paracetamol (Adol, Julphar Pharmaceutical Industries,
UAE) 20 mg/kg was given.
The same surgeon performed all the operations; at the end
of surgery, sevoﬂurane and N2O were discontinued, muscle
relaxant was reversed using neostigmine and atropine after re-
turn of at least two of the train-of-four by peripheral nerve
stimulator and proper suction of the throat under vision,
and the patients were put in the recovery position and extubat-
ed after displaying a regular respiratory pattern, purposeful
movement, and return of the swallow reﬂex. After extubation,
100% O2 were applied by face mask till the patient open his
eyes in response to verbal commands and then shifted to the
recovery room for observation and monitoring until they reach
a score 9 or more on Modiﬁed Aldrete score [11] before dis-
charging to the ward.
The following variables were recorded during the study.
 Demographic data.
 The duration of operation: (the time between applica-
tion and removal of the mouth gag).
 The duration of anesthesia: (the time from induction of
anesthesia till extubation).
 The duration of extubation: (the time from discontinu-
ation of the anesthetic till extubation).
 The duration of emergence: (the time from the discon-
tinuation of anesthesia to the time of eye opening on
verbal command).
 State of emergence at the time of admission to recovery
room using emergence agitation scale [12], Table 1; for
our study, the score of 4 or more was considered agita-
tion and needs treatment with increments of fentanyl
1 lg/kg slowly intravenously with close monitoring
for any signs of respiratory depression and can be
repeated if needed at 10 min intervals.
The effect of nebulized lidocaine hydrochloride on emergence from sevoﬂurane anesthesia 353 The number of patients needed postoperative fentanyl.
 The duration of discharge from the recovery room
(from arrival to the recovery room until discharge).
 Vital signs (heart rate, blood pressure, and oxygen sat-
uration) were monitored in recovery room on admis-
sion (T0) and every 10 min until discharge.
 Nausea and vomiting using a 4-degree scale [6]: 0 = no
nausea and vomiting; 1 = nausea only; 2 = single
vomiting episode; 3 = multiple vomiting episodes.
(Treated with Ondansetron 0.15 mg/kg).
 Respiratory depression detected by O2 desaturation.
 Hallucination.
1.2. Statistical analysis
Data were statistically described in terms of mean ± standard
deviation (±SD), or frequencies (number of cases) and per-
centages when appropriate. Comparison of numerical vari-
ables between the study groups was done using Student t test
for independent samples. For comparing categorical data,
Chi square (v2) test was performed. Exact test was used instead
when the expected frequency is less than 5. P values less than
0.05 was considered statistically signiﬁcant. All statistical cal-
culations were done using computer programs SPSS (Statisti-
cal Package for the Social Science; SPSS Inc., Chicago, IL,
USA) version 15 for Microsoft Windows.
The sample size was calculated to be 36 patients in each
group depending on the results from previous studies; we as-
sumed a reduction in the incidence of agitation from 60% to
30% with the a-error level ﬁxed at 0.05 and the power was
set at 90%. We were expecting some exclusions and failureFigure 1 Mean duration of anesthesia (min), extubation (min), emerg
groups. \p value is signiﬁcant. Group L (lidocaine group), group P (p
Table 2 Demographic data and duration of operation.
Variables Group L (n= 38) Group P (n= 39) p value
Age (year) 5.17 ± 1.08 5.24 ± 1.14 0.783
Gender (male/female) 20/18 19/20 0.906
Body weight (kg) 17.3 ± 2.5 16.90 ± 3.4 0.559
Duration of operation 40.43 ± 1.0 40.32 ± 1.2 0.664
Data are presented as mean ± SD or numbers. No signiﬁcant
differences between groups.to follow up during the course of the study, so we increased
the number of the sample size to 40 patients per each group.
2. Results
The demographic data and anesthesia time were presented in
Table 2. Two patients in group L were excluded from the study
both due to surgery exceeded 1 h, one patient in group P was
excluded due to bleeding at the surgical site after extubation.
The two groups were comparable regarding age, sex, weight,
and operative time.
The duration of anesthesia, extubation, and emergence was
prolonged in group L compared to group P; (46.10 ± 1.6 min)
versus (44.31 ± 3.2 min) p value 0.003, (5.11 ± 1.3 min) ver-
sus (4.2 ± 1.0 min) p value 0.001 and (10.30 ± 2.1 min) versus
(7.44 ± 3.3 min) p value 0.00, respectively. While the duration
of stay in recovery room were comparable in both group L and
group P (29.12 ± 3.3 min) and (30.10 ± 2.1 min) respectively,
p value 0.123, (Fig. 1).
In the recovery room, there was a signiﬁcantly lower values
of heart rate and mean arterial blood pressure in group L com-
pared to group P, (Figs. 2 and 3). The mean heart rate for
group L and P, at T0 (111 ± 2.4) and (119 ± 3.2), at T10
(105 ± 2.3) and (110 ± 1.2), at T20 (103 ± 2.5) and
(108 ± 1.1), at T30 (102 ± 3.1) and (107 ± 2.5) respectively,
p value (0.00).
The mean arterial blood pressure for group L and group P;
at T0 (59 ± 3.2) and (63 ± 1.0), at T10 (60 ± 1.2) and
(64 ± 2.2), at T20 (62 ± 2.3) and (64 ± 4.1), at T30
(62 ± 1.0) and (64 ± 1.4) respectively, p value at all times
was (0.00).
The peripheral oxygen saturation was comparable in both
groups, (Fig. 4) shows the mean oxygen saturation (%) in
the recovery room in group L and group P respectively; at
T0 (96.4 ± 2) and (97.02 ± 1.6), p value (0.137), at T10
(97.63 ± 1.3) and (97.23 ± 1.7), p value (0.249), at T20
(98.1 ± 2) and (97.51 ± 1.2), p value (0.120), at T30
(98.61±1.6) and (99.04±1.4), p value (0.213).
The incidence and degree of agitation in both groups are
represented in Table 3.
The number of agitated patients (P grade 4) who required
fentanyl was signiﬁcantly lower in group L; 8 out of 38
(20.5%) than in group P; 20 out of 39 (51.5%), p value
(0.012), Fig. 5.ence (min), and stay in the recovery room (min) between the study
lacebo group).
Figure 2 Mean heart rate (beats/min) between the 2 groups over the study period in the recovery room T0 (at admission), T10 (after
10 min), T20 (after 20 min), and T30 (after 30 min). Group L (lidocaine group), group P (placebo group). \p value was signiﬁcant.
Figure 3 Mean mean arterial blood pressure (mmHg) between the 2 groups over the study period in the recovery room T0 (at
admission), T10 (after 10 min), T20 (after 20 min), and T30 (after 30 min). Group L (lidocaine group), group P (placebo group). \p value
was signiﬁcant.
Figure 4 Mean oxygen saturation (%) between the 2 groups over the study period in the recovery room T0 (at admission), T10 (after
10 min), T20 (after 20 min), and T30 (after 30 min).Group L (lidocaine group), group P (placebo group).
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ing the incidence of nausea, vomiting, respiratory depression,
and hallucination Table 4.
3. Discussion
Sevoﬂurane-related EA was reported to be up to 80% and is
considered as a signiﬁcant post-anesthetic problem that
interferes with safe and smooth recovery [2]; usually, it is
self-limited (15–30 min) [13]. The exact etiology of sevoﬂu-
rane-related EA is still unclear. Studies have reported EAdespite adequately treated pain [14,18] or even when pain
was absent [18]. Also, it was thought that rapid awakening
after the use of the insoluble anesthetics, as sevoﬂurane, may
cause EA [19]. But the recovery from propofol which is also ra-
pid and pleasant was associated with less incidence of EA [18].
However, inadequate analgesia may play an important role,
especially after short surgical procedures as adenotonsillec-
tomy since the maximum effect of analgesics may be delayed
until the child is completely awake [13,14]. Hence, adequate
analgesia as a goal to approach is very essential to prevent
EA. Different pharmacological interventions had been tested
Table 3 Incidence and degree of agitation.
Agitation score Group L (n= 38) Group P (n= 39) p value
Grade 1 0(0) 0(0) 1
Agitated patients 0.031*
Grade 2 8(21%) 6(15%)
Grade 3 22(58%) 13(33.5%)
Grade 4 7(18.5%) 13(33.5%)
Grade 5 1(2.5%) 7(18%)
Number of patients with agitation scoreP 4 8(20.5%) 20(51.5%) 0.012*
Values are presented as number of patients and percentages. Group L = lidocaine group, group P = placebo group.
* p value is signiﬁcant.
Figure 5 Percentage of cases who needed fentanyl treatment
between the 2 study groups. \p value was signiﬁcant, group L;
lidocaine group, group P; placebo group.
Table 4 Incidence of side effects in the recovery room,
represented by number of patients and percentages.
Variable Group L (n= 38) Group P (n= 39) p value
Nausea 2(5%) 3(7.5%) 0.976
Vomiting 0(0%) 1(2.5%) 0.990
Respiratory depression 0(0%) 0(0%) 1
Hallucination 0(0%) 0(0%) 1
Values are represented as number or percentage. Group
L = lidocaine group, group P = placebo group.
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tion of I.V. ketorolac 1 mg/kg for minor otorhinolaryngologi-
cal procedures decreased the incidence of EA three to four
times, after both halothane and sevoﬂurane anesthesia [15].
Fentanyl administered either I.V. 2.5 lg/kg [4] or intranasal
2 lg/kg [16] also decreased the incidence of EA. Similarly, pro-
pofol, ketamine, dexamethasone, and clonidine [5,7,1,17] have
been found to be effective. Unfortunately, all the above men-
tioned pharmacological interventions can lead to undesired
side effects especially for adenotonsillectomy pediatric pa-
tients, namely oversedation in recovery room or bleeding.
In this study, to optimize the pain management in our pa-
tients, we used low dose ketamine (1 mg/kg) intravenously as
a premedication, intravenous fentanyl (2 lg/kg) with induction
of anesthesia, and paracetamol suppository (20 mg/kg) imme-
diately after intubation.
We chose nebulized lidocaine in a dose of 4 mg/kg; as it was
reported by Gjonaj et al. to be safe and well tolerated when
used in pediatric patients undergoing bronchoscopy and the
lidocaine levels tested was found always below the toxic level[10]. Moreover, the standard nebulized dose in adult is 4 mL
of 4% lidocaine which is approximately equal to 4 mg/kg for
pediatric [20] and the maximum squirted pediatric dose was
found to be 8.5 mg/kg [21].
Jee et al has compared lidocaine given by the intravenous
route with lidocaine sprayed down the endotracheal tube
(ETT), and they found that at the same dose, lidocaine sprayed
directly down the ETT had attenuated the airway reﬂexes
while the lidocaine administered intravenously did not. And
they attributed this to the direct local-mucosal anesthetizing ef-
fect of the sprayed lidocaine rather than a systemic absorption
from the airway [22].
In our study, the durations of anesthesia, extubation, and
emergence were signiﬁcantly prolonged in the lidocaine group,
and this may be explained by the mucosal analgesia and
blunted noxious stimulation as a direct topical effect of nebu-
lized lidocaine; however, a systemic effect of nebulized lido-
caine may has contributed as well.
Also, nebulized lidocaine had attenuated the cardiovascular
response during the 30 min stay in the recovery room, which is
an indication to patient comfort and adequate analgesia com-
pared to the placebo group.
The incidence and degree of agitation have been signiﬁ-
cantly reduced by nebulized lidocaine, with no side effects, this
again may be related to the preemptive analgesic effect of lido-
caine, this analgesic effect seems to last to cover the emergence
and early postoperative period, since the inhalation of lido-
caine results in a much higher airway concentrations and lower
plasma concentrations [23]. This ﬁnding also matches with
Groeben et al., 1999 who tested the effect of lidocaine given
by inhalation and by intravenous infusion on attenuating air
way reﬂexes. And they found that the plasma concentrations
of Meg X, which is the ﬁrst metabolite of lidocaine, have a
much longer-lasting plateau following lidocaine inhalation
than following intravenous administration, suggesting pro-
longed absorption of lidocaine from the airway into the blood
stream. Also, Meg X plasma concentrations continued to in-
crease for 40 min after completion of inhalation, while its peak
plasma concentrations were already reached after 10 min of
termination of intravenous infusion of lidocaine [24].
In conclusion, the use of nebulized lidocaine hydrochloride
before sevoﬂurane anesthesia for tonsillectomy in pediatrics
attenuated the sevoﬂurane-related emergence agitation with
no side effects.
Limitations of this study:
We used the ﬁve-point agitation scale for measuring the
degree of agitation, although the Pediatric Anesthesia
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2004 [25], seems to be themost reliable tool for themeasurement
of EA; but it was difﬁcult for us to train the observers to apply it
in a short time. Therefore, we depended on the simpler and rap-
idly applicable ‘‘Five-point scale.’’
This study was done only in children between 4 and 6 years,
and further studies are needed on other age groups.
To keep it blinded, we had to ﬁx the volume of tested drug
which means variable lidocaine concentration, which might af-
fected the pharmacokinetics of the drug.
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